No abstract available
MeSH terms
-
Follow-Up Studies
-
Heart Transplantation / immunology*
-
Heart-Lung Transplantation / immunology*
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Lymphoma, Non-Hodgkin / epidemiology
-
Middle Aged
-
Muromonab-CD3 / adverse effects
-
Muromonab-CD3 / therapeutic use
-
Neoplasms / epidemiology*
-
Neoplasms / etiology
-
Retrospective Studies
-
Risk Factors
-
Skin Neoplasms / epidemiology
-
Time Factors
Substances
-
Immunosuppressive Agents
-
Muromonab-CD3